[{"_id":"551f89b631cae9239deb1ecb","会社名":"武田薬品工業(株)【4502】","証券コード":"4502","決算期":"2014年3月期","会計方式":"IFRS基準","決算発表日":"2014年5月8日","決算月数":"12か月","売上高":"1,691,685百万円","営業利益":"139,274百万円","経常利益":"158,851百万円","当期利益":"106,658百万円","EPS（一株当たり利益）":"135.10円","調整一株当たり利益":"134.95円","BPS（一株当たり純資産）":"3,129.63円","総資産":"4,569,144百万円","自己資本":"2,470,739百万円","資本金":"63,562百万円","有利子負債":"859,984百万円","自己資本比率":"54.1%","ROA（総資産利益率）":"2.50%","ROE（自己資本利益率）":"4.61%","総資産経常利益率":"3.73%","__v":0,"日付":"2015-04-04T06:50:30.069Z"},{"_id":"551f89b631cae9239deb1ecc","会社名":"武田薬品工業(株)【4502】","証券コード":"4502","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月9日","決算月数":"12か月","売上高":"1,557,267百万円","営業利益":"122,505百万円","経常利益":"113,168百万円","当期利益":"131,244百万円","EPS（一株当たり利益）":"166.25円","調整一株当たり利益":"166.21円","BPS（一株当たり純資産）":"2,734.79円","総資産":"3,955,599百万円","自己資本":"2,159,007百万円","資本金":"63,541百万円","有利子負債":"541,954百万円","自己資本比率":"54.6%","ROA（総資産利益率）":"3.48%","ROE（自己資本利益率）":"6.29%","総資産経常利益率":"3.00%","__v":0,"日付":"2015-04-04T06:50:30.069Z"},{"_id":"551f89b631cae9239deb1ecd","会社名":"武田薬品工業(株)【4502】","証券コード":"4502","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月11日","決算月数":"12か月","売上高":"1,508,932百万円","営業利益":"265,027百万円","経常利益":"270,330百万円","当期利益":"124,162百万円","EPS（一株当たり利益）":"157.29円","調整一株当たり利益":"157.26円","BPS（一株当たり純資産）":"2,548.53円","総資産":"3,577,030百万円","自己資本":"2,011,840百万円","資本金":"63,541百万円","有利子負債":"542,804百万円","自己資本比率":"56.2%","ROA（総資産利益率）":"3.90%","ROE（自己資本利益率）":"6.05%","総資産経常利益率":"8.50%","__v":0,"日付":"2015-04-04T06:50:30.069Z"}]